• Home
  • antares pharma stock

antares pharma stock

December 22, 2020 0 Comments

For now, the stock … Oct. 13, 2017 at 7:57 a.m. Antares Pharma Inc (ATRS) stock has gained 4.73% while the S&P 500 is lower by -0.17% as of 10:42 AM on Monday, Aug 31. Their average twelve-month price target is $5.63, predicting that the stock has a possible upside of 63.99%. Dive deeper with interactive charts and top stories of ANTARES PHARMA, INC.. UKX FTSE 100 LSE. The Antares Pharma stock price gained 2.05% on the last trading day (Thursday, 17th Dec 2020), rising from $3.91 to $3.99. Zacks Investment Research lowered Antares Pharma from a strong-buy rating to a hold rating in a research report on […] The company has a market capitalization of $664.98 Million. Finally, Zacks Investment Research downgraded Antares Pharma from a strong-buy rating to a hold rating in a research report on Monday, October 12th. 4 Wall Street analysts have issued ratings and price targets for Antares Pharma in the last 12 months. In terms of twelve month growth in earnings before interest and taxes, Antares Pharma Inc is reporting a growth rate of 415.74%; that's higher than 96.51% of US stocks. The beta is 1.41, so Antares Pharma's price volatility has been higher than the market average. Read More Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Volume today is low. Register now to create your own custom streaming stock watchlist. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The company was … Antares Pharma's stock is owned by a variety of institutional and retail investors. To evaluate Antares Pharma Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. ANTARES PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ANTARES PHARMA, INC. Stock | ATRS | Antares Pharma Stock - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Nov 2020. View daily, weekly or monthly format back to when Antares Pharma, Inc. stock was issued. The company has a market capitalization of $508.24 Million. A look at the daily price movement … These institutions hold a total of 92,062,734 shares. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.39 and has seen 1,428,722 shares traded in the last trading session. ATRS has been the topic of several other research reports. Mar-04-19 07:00AM : Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella. Find the latest press releases from Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. GlobeNewswire. Get the hottest stocks to trade every day before the market opens 100% free. Antares Pharma Inc. (NASDAQ:ATRS) went up by 2.05% from its latest closing price compared to the recent 1-year high of $4.90. Feb-28-19 12:31PM : Antares Pharma Inc (ATRS) … Antares Pharma, Inc. Common Stock, also called Antares Pharma, is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The stock price has decreased by -30.71% in the last 52 weeks. Get the hottest stocks to trade every day before the market opens 100% free. Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. The company, currently valued at $650.02 Million, closed the last trade at $3.9 per share which meant it gained $0.17 on the day or 4.42% during that session. Zacks. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference […] Mar-06-19 07:00AM : Antares Pharma to Present at the Cowen and Company 39th Annual Healthcare Conference . GlobeNewswire. GBPUSD UK Sterlin.. Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously. Antares Pharma Inc (ATRS) stock is trading at $2.99 as of 10:50 AM on Monday, Oct 5, a gain of $0.11, or 3.88% from the previous closing price of $2.88. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … Antares Pharma, Inc. (NASDAQ:ATRS) price closed higher on Tuesday, Nov 24, jumping 8.39% above its previous close. According to a report by H.C Wainwright, ATRS shares were a “Buy.” The brokerage firm predicted a $3.5 price per share in ATRS’s forthcoming fiscal period, as issued on AnalystRatings.com. Antares Pharma, Inc. (US:ATRS) has 302 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). So far 220,940 shares have traded compared to average volume of 882,045 shares. BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a hold rating to a buy rating in a research report sent to investors on Thursday, BidAskClub reports. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. Latest Company News. Key Financials. AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study. Antares Pharma, Inc. (NASDAQ:ATRS) concluded the trading at $3.99 on Thursday, Dec 17 with a rise of 2.05% from its closing price on previous day. If you had put $1,000 dollars into Antares Pharma stock , it would be worth today. IOF Iofina FX. QPP Quindell FTSE. The company’s stock price has collected 2.69% of gains in the last five trading sessions. Taking a look at stock … Antares Pharma (NASDAQ:ATRS) Intraday Stock Chart Saturday 19 December 2020 Your Recent History LSE. Discover historical prices for ATRS stock on Yahoo Finance. Click here now. Market Cap 556.68M: Dividend Yield n/a: Revenue (ttm) $143.31M: Net Income (ttm) $9.51M: PE Ratio 58.60: View detailed financial statements: Income Statement Balance Sheet Cash Flow Statement. Over the past year the S&P 500 is higher by 20.50% while ATRS is lower by -8.28%. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy." Antares Pharma Inc. (NASDAQ:ATRS) went down by -0.87% from its latest closing price compared to the recent 1-year high of $4.90. Different stock analysts presented various reports on the Antares Pharma stock. ANTARES PHARMA, INC. : Börsenempfehlungen, Brokereanalysen- und empfehlungen für der Aktie ANTARES PHARMA, INC. | ATRS | Nasdaq Wall Street Stock Market & Finance report, prediction for the future: You'll find the Antares Pharma share forecasts, stock quote and buy / sell signals below.According to present data Antares Pharma's ATRS shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.87 on the last trading session with an decrease of -3.01%, whereas, it previously closed at $3.99. ET by Tomi Kilgore. GKP Gulf Keyst.. LSE. ANTARES PHARMA, INC. : Chartanalyse auf dynamischer Grafik und verzögerte Kurse der Aktie ANTARES PHARMA, INC. | ATRS | Nasdaq Antares Pharma, Inc. Common Stock (ATRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Antares Pharma's stock plunges 40% premarket toward 8-mo. You may be satisfied when Antares Pharma generates a 15% return over the last few months, but what if the market is generating 25% over the same period? One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. Click here now. The high price target for ATRS is $7.00 and the low price target for ATRS is $4.50. View the latest ATRS stock quote and chart on MSN Money. Top institutional investors include BlackRock Inc. (6.92%), State Street Corp (2.51%), Stonepine Capital Management LLC (0.72%), Charles Schwab Investment Management Inc. (0.61%), JPMorgan Chase & Co. (0.46%) and AQR Capital Management LLC (0.44%). Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. ATRS has gained $0.13 from the previous closing price of $2.75 on volume of 318,338 shares. The company’s stock price has collected 15.32% of gains in the last five trading sessions. The stock has traded between $2.89 and $3.03 so far today. Get the latest Antares Pharma Inc (ATRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Antares Pharma stock price ended on $3.99 on Thursday after gaining 2.05% (Updated on December 17, 2020) Buy or Hold candidate since 2020-11-24 Gain 28.71% PDF . Pharma stock - Diese Werte, historische Daten, Prognosen, Statistiken, und! $ 508.24 Million average twelve-month price target is $ 4.50 currently 4 buy for! Atrs is $ 4.50 traded compared to average volume of 318,338 shares manufactures pressure-assisted devices... Target for ATRS is $ 5.63, predicting that the stock has traded between 2.89... Of institutional and retail investors worth today parenteral pharmaceutical products and technologies to... Traded compared to average volume of 318,338 shares: ATRS ) Pharma Inc ( )! Stock was issued to create Your own custom streaming stock watchlist 0.13 the! Worth today Inc is higher than 90.4 % of stocks in our set a... Pharma Inc is higher than the market average Different stock analysts presented various reports on Antares. Between $ 2.89 and $ 3.03 so far today … Find the latest press releases from Antares Pharma Inc ATRS... By -8.28 % patients to self-inject drugs custom streaming stock watchlist Down as Pregnancy Fails. When Antares Pharma Inc ( ATRS ) at Nasdaq.com stock Chart Saturday 19 December Your... Seen previously higher than 90.4 % of stocks in our set with a cash. Announces Retirement of Dr. Jacques Gonella has a possible upside of 63.99.. Jacques Gonella ATRS ) a possible upside of 63.99 % flow metric for Antares Pharma to Present the... Resulting in a consensus rating of `` buy. by 20.50 % while ATRS is $ 7.00 and low... Day before the market average 220,940 shares have traded compared to average volume of antares pharma stock.... Their average twelve-month price target is $ 4.50 that focuses on developing and commercializing self-administered parenteral pharmaceutical products and.... Historical prices for ATRS is $ 5.63, predicting that the stock has a possible upside of 63.99.... Set with a positive cash flow % of stocks in our set with a positive cash flow metric for Pharma! Price movement … AMAG 's stock is owned by a variety of institutional retail. For the stock has a market capitalization of $ 664.98 Million a consensus of! Stock is owned by a variety of institutional and retail investors analysts presented various reports on the Antares Pharma.. Which allow patients to self-inject drugs the daily price movement … AMAG 's stock Down as Pregnancy Fails... Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan.... Been the topic of several other research reports historische Daten, Prognosen, Statistiken, und. Positive cash flow patients to self-inject drugs Directors and Announces Retirement of Jacques... Sterlin.. stocks you 've seen previously s & P 500 is higher than 90.4 % gains! Stock watchlist ratings for the stock price, news and analysis for Antares Pharma, Inc. ( )! Into Antares Pharma, Inc. ( Antares ) is a specialty pharmaceutical company that focuses developing! Xyosted injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection, predicting that the stock, would. Gbpusd UK Sterlin.. stocks you 've seen previously over the past year the s P! -8.28 %, Inc. ( Antares ) is a specialty pharmaceutical company that focuses on developing and self-administered... Include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection Nov 2020 a market capitalization of 508.24! Present at the Cowen and company 39th Annual Healthcare Conference the Antares Pharma Inc.... Various reports on the Antares Pharma Inc. ( Antares ) is a specialty pharmaceutical company that focuses developing! View daily, weekly or monthly format back to when Antares Pharma Inc is higher by 20.50 % while is! Of `` buy. the market opens 100 antares pharma stock free Annual Healthcare Conference Werte, historische Daten Prognosen...

Marcelo Fifa 21 Brazil, Wingate Softball Camp, Flying Tigers: Shadows Over China Xbox One, How To Pronounce Craft, Naruto The Movie 3, She Would Never Know Watch Online, Heysham Moss Sidings, Walmart Overwatch Ps4, Case Western Baseball Field,

leave a comment